Related Experiment Videos
Optimizing blood pressure in neurological emergencies.
1Department of Neurology, Columbia University College of Physicians and Surgeons, New York, NY 10032, USA.
Neurocritical Care
|September 22, 2005
Summary
Managing blood pressure (BP) in neurological emergencies is critical. Optimal BP management strategies are needed due to limited high-quality evidence, guiding the choice of specific antihypertensive and hypertensive agents.
Area of Science:
- Neurology
- Critical Care Medicine
- Pharmacology
Background:
- Hypertension and hypotension significantly impact cerebral blood flow autoregulation, intracranial pressure (ICP), and cerebral edema.
- Limited high-quality evidence (Class I/II) exists for optimal blood pressure (BP) management in neurological emergencies.
- Current guidelines rely heavily on low-grade evidence (Class III).
Purpose of the Study:
- To review the current evidence for BP management in neurological emergencies.
- To identify optimal pharmacological agents for BP reduction and elevation in specific neurological conditions.
- To guide clinical practice in managing BP in patients with conditions like stroke, subarachnoid hemorrhage, and traumatic brain injury.
Main Methods:
- Review of existing clinical guidelines and evidence grading (Class I, II, III).
- Analysis of pharmacological agents for BP management based on efficacy, safety, and pharmacokinetic profiles.
- Synthesis of data regarding BP targets in acute ischemic stroke, aneurysmal subarachnoid hemorrhage, eclampsia, and traumatic brain injury.
Main Results:
- Class I evidence supports candesartan for ischemic stroke, nimodipine for subarachnoid hemorrhage (SAH), and magnesium for eclampsia.
- Class II evidence supports specific BP targets for ischemic stroke treated with tPA, SAH with vasospasm, and traumatic brain injury (maintaining CPP > 60 mmHg).
- Labetalol, esmolol, and nicardipine are recommended for BP reduction due to favorable profiles; phenylephrine, dopamine, and norepinephrine for BP elevation. Sodium nitroprusside should be used cautiously due to ICP elevation risks.
Conclusions:
- Optimal BP management in neurological emergencies requires careful consideration of available evidence and patient-specific factors.
- Short-acting, continuous-infusion agents with predictable effects are preferred for BP modulation.
- Specific agents are recommended for BP reduction (labetalol, esmolol, nicardipine) and elevation (phenylephrine, dopamine, norepinephrine) in neurological emergencies, while sodium nitroprusside should be avoided where possible.